$90.78
9.26% today
NYSE, Apr 03, 06:46 pm CET
ISIN
US3773221029
Symbol
GKOS

Glaukos Corp Stock price

$100.04
-9.11 8.35% 1M
-28.43 22.13% 6M
-49.90 33.28% YTD
+10.56 11.80% 1Y
+38.14 61.62% 3Y
+70.00 233.02% 5Y
+68.82 220.44% 10Y
NYSE, Closing price Wed, Apr 02 2025
+2.95 3.04%
ISIN
US3773221029
Symbol
GKOS
Sector

Key metrics

Market capitalization $5.66b
Enterprise Value $5.45b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 14.20
P/S ratio (TTM) P/S ratio 14.76
P/B ratio (TTM) P/B ratio 7.36
Revenue growth (TTM) Revenue growth 21.85%
Revenue (TTM) Revenue $383.48m
EBIT (operating result TTM) EBIT $-108.14m
Free Cash Flow (TTM) Free Cash Flow $-67.62m
Cash position $318.92m
EPS (TTM) EPS $-2.81
P/E forward negative
P/S forward 11.77
EV/Sales forward 11.33
Short interest 10.37%
Show more

Is Glaukos Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Glaukos Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Glaukos Corp forecast:

14x Buy
88%
1x Hold
6%
1x Sell
6%

Analyst Opinions

16 Analysts have issued a Glaukos Corp forecast:

Buy
88%
Hold
6%
Sell
6%

Financial data from Glaukos Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
383 383
22% 22%
100%
- Direct Costs 94 94
34% 34%
25%
289 289
18% 18%
75%
- Selling and Administrative Expenses 221 221
19% 19%
58%
- Research and Development Expense 136 136
2% 2%
36%
-68 -68
14% 14%
-18%
- Depreciation and Amortization 40 40
5% 5%
10%
EBIT (Operating Income) EBIT -108 -108
8% 8%
-28%
Net Profit -146 -146
9% 9%
-38%

In millions USD.

Don't miss a Thing! We will send you all news about Glaukos Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Glaukos Corp Stock News

Neutral
Business Wire
23 days ago
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Topcon Healthcare, Inc., RadiusXR, and Glaukos Corporation (NYSE: GKOS) announced a new collaboration and the launch of RadiusXR's new wearable vision testing platform - Inspire®. This collaboration unites RadiusXR's innovative visual field platform and Topcon Healthcare's global leadership in robotic diagnostics and digital healthcare solutions with Glauko...
Neutral
Business Wire
about one month ago
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced it has received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application ...
Neutral
Seeking Alpha
about one month ago
Glaukos Corporation (NYSE:GKOS ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Chris Lewis - Vice President, Investor Relations and Corporate Affairs Tom Burns - Chairman and Chief Executive Officer Joe Gilliam - President and Chief Operating Officer Conference Call Participants Tom Stephen - Stifel Richard Newitter - Truist Securities Allen Gong - JPMorgan ...
More Glaukos Corp News

Company Profile

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.

Head office United States
CEO Thomas Burns
Employees 995
Founded 1998
Website www.glaukos.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today